High-Throughput Cytokine & Chemokine Profiling by Multiplexing
High-Throughput Cytokine & Chemokine Profiling by Multiplexing
Understanding the complex interplay of the immune system requires looking beyond single analytes. At ImmunitasBio, we utilize Luminex® xMAP® technology to provide high-throughput, multiplexed quantification of cytokines and chemokines. By measuring dozens of biomarkers simultaneously from a single, ultra-low-volume sample, we deliver the comprehensive systemic profiles needed to drive fast, informed decisions in your preclinical and translational programs.
Our bespoke multiplexing services deliver robust biomarker data across a wide range of therapeutic and commercial applications:
Species-Specific & Cross-Reactive Panels:
Simultaneous quantification of 45+ soluble targets in human, mouse, rat, NHP, and canine biofluids (serum, plasma, CSF, tissue homogenates).
Biomarker Signature Discovery:
Identify predictive efficacy and safety biomarkers early in the drug development pipeline, streamlining lead selection, dose optimization, and the transition toward IND-enabling studies.
CRS Risk & Safety Screening:
Early in vitro cytokine release assays using human whole blood/PBMCs paired with in vivo cytokine storm profiling from preclinical animal cohorts.
Translational Biomarker Bridging
Correlate systemic inflammatory and chemokine signatures between preclinical efficacy models and human primary assays.
